Copyright
©The Author(s) 2022.
World J Diabetes. Aug 15, 2022; 13(8): 622-642
Published online Aug 15, 2022. doi: 10.4239/wjd.v13.i8.622
Published online Aug 15, 2022. doi: 10.4239/wjd.v13.i8.622
Table 3 Ultra-performance liquid chromatography full spectrum identification results
No. | Name | CAS | Molecular weight | RT (min) | Relative concentration (μg/mL) |
1 | DL-Arginine | 7200-25-1 | 174.11175 | 0.783 | 24.44253696 |
2 | Nitrosobis(2-oxopropyl)amine | 60599-38-4 | 158.06914 | 0.817 | 15.74503993 |
3 | Gluconic acid | 526-95-4 | 196.05765 | 0.821 | 82.48616363 |
4 | D-(+)-Proline | 344-25-2 | 115.06357 | 0.846 | 15.35704499 |
5 | Cabotegravir | 1051375-10-0 | 405.11182 | 0.847 | 20.08010135 |
6 | α,α-Trehalose | 99-20-7 | 342.11623 | 0.847 | 409.0449144 |
7 | D-(-)-Quinic acid | 77-95-2 | 192.06275 | 0.85 | 56.2670819 |
8 | Isocitric acid | 320-77-4 | 192.02637 | 0.939 | 63.29259087 |
9 | Citric acid | 77-92-9 | 192.02637 | 1.169 | 145.2856943 |
10 | Gallic acid | 149-91-7 | 170.02078 | 1.899 | 23.57871448 |
11 | Chlorogenic acid | 327-97-9 | 354.09527 | 5.332 | 44.58986172 |
12 | Catechin | 88191-48-4 | 290.07917 | 5.431 | 98.07463825 |
13 | methyl chlorogenate | 123483-19-2 | 368.11081 | 5.501 | 18.15074983 |
14 | 6-Acetylcodeine | 6703-27-1 | 341.16237 | 5.886 | 12.3548527 |
15 | 2-(3,4-Dihydroxyphenyl)ethyl 3-O-(6-deoxy-β-L-mannopyranosyl)-6-O-[(2E)-3-(3,4-dihydroxyphenyl)-2-propenoyl]-β-D-glucopyranoside | 61303-13-7 | 624.20617 | 6.092 | 20.78761602 |
16 | (3R,5R)-1,3,5-Trihydroxy-4-{[(2E)-3-(4-hydroxy-3-methoxyphenyl)-2-propenoyl]oxy}cyclohexanecarboxylic acid | 2613-86-7 | 368.11084 | 6.196 | 201.3429867 |
17 | Emodin-8-Beta-D-Glucoside | 23313-21-5 | 432.10571 | 6.579 | 7.280885459 |
18 | 2-[4-[3-[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-7-hydroxy-2,3-dihydrochromen-4-one | 74639-14-8 | 550.16902 | 6.625 | 13.98565399 |
19 | Baicalin | 21967-41-9 | 446.0852 | 6.663 | 16.85569046 |
20 | Liquiritin | 551-15-5 | 418.12676 | 6.737 | 22.91985259 |
21 | Naringin | 10236-47-2 | 580.17964 | 6.959 | 26.36327029 |
22 | Hesperidin | 520-26-3 | 610.19038 | 7.191 | 85.82076776 |
23 | Azelaic acid | 123-99-9 | 188.1042 | 7.548 | 4.773123466 |
24 | Berberine | 2086-83-1 | 335.11525 | 8.242 | 232.2489146 |
25 | isosakuranetin-7-O-rutinoside | 14259-47-3 | 594.19556 | 8.493 | 4.34803523 |
26 | Tinnevellin glucoside | 80358-06-1 | 408.14228 | 8.786 | 13.59498227 |
27 | Daidzein | 486-66-8 | 254.05778 | 9.009 | 13.05981793 |
28 | Chrysophanol 8-O-β-D-glucoside | 13241-28-6 | 416.11099 | 9.01 | 17.88080565 |
29 | Licoricesaponin G2 | 118441-84-2 | 838.39998 | 9.824 | 7.195669531 |
30 | Luteolin | 491-70-3 | 286.04776 | 9.909 | 1.034661042 |
31 | (15Z)-9,12,13-Trihydroxy-15-octadecenoic acid | 95341-44-9 | 330.24071 | 9.938 | 19.41925634 |
32 | Rheic acid | 478-43-3 | 284.03211 | 11.029 | 81.8044913 |
33 | Bisdemethoxycurcumin | 24939-16-0 | 308.10496 | 11.328 | 153.9247824 |
34 | 6-Hydroxy-2-naphthoic acid | 16712-64-4 | 188.04652 | 11.328 | 7.047135466 |
35 | Demethoxycurcumin | 22608-11-3 | 338.11567 | 11.473 | 151.9906609 |
36 | 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-6-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one | 76735-58-5 | 370.14168 | 11.541 | 55.08087646 |
37 | Curcumin | 458-37-7 | 368.12606 | 11.619 | 307.1972754 |
38 | Isoimperatorin | 482-45-1 | 270.08918 | 11.847 | 1.025466018 |
39 | Genistein | 446-72-0 | 270.05279 | 12.256 | 153.8276373 |
40 | (+/-)9-HODE | 98524-19-7 | 296.23511 | 13.146 | 23.43829567 |
41 | (+)-ar-Turmerone | 532-65-0 | 216.15135 | 13.605 | 23.84749189 |
42 | Indane | 496-11-7 | 118.07843 | 13.605 | 27.63249372 |
43 | Prespatane | 100387-71-8 | 204.18777 | 13.956 | 2.010509748 |
44 | (+)-Nootkatone | 4674-50-4 | 218.16696 | 14.497 | 16.6606139 |
45 | Aristolone | 6831-17-0 | 218.16696 | 14.588 | 45.88543598 |
46 | 2,2'-Methylenebis(4-methyl-6-tert-butylphenol) | 119-47-1 | 340.24015 | 16.788 | 25.70628216 |
- Citation: Li XY, Zhang XT, Jiao YC, Chi H, Xiong TT, Zhang WJ, Li MN, Wang YH. In vivo evaluation and mechanism prediction of anti-diabetic foot ulcer based on component analysis of Ruyi Jinhuang powder. World J Diabetes 2022; 13(8): 622-642
- URL: https://www.wjgnet.com/1948-9358/full/v13/i8/622.htm
- DOI: https://dx.doi.org/10.4239/wjd.v13.i8.622